[Enzymes as starting points for pharmaceutical development].
D000970:Antineoplastic Agents / Q000494:pharmacology; D055598:Chemical Phenomena; D002621:Chemistry; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004359:Drug Therapy, Combination; D004791:Enzyme Inhibitors / Q000494:pharmacology; D004798:Enzymes / Q000494:pharmacology*; D010406:Penicillins / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D013940:Thymidylate Synthase / Q000037:antagonists & inhibitors; D014295:Trimethoprim / Q000494:pharmacology
D000970:Antineoplastic Agents; D002800:Cholinesterase Inhibitors; D004791:Enzyme Inhibitors; D004798:Enzymes; D010406:Penicillins; D013449:Sulfonamides; D014295:Trimethoprim; D013940:Thymidylate Synthase
Enzyme als Ansatzpunkte der Arzneistoffentwicklung.